Matthew R. Lockett

Matthew R. Lockett

Auto-generated profile, based on publicly available information

Matthew R. Lockett

Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PSPhillip W. Snyder
Phillip W. Snyder
Jasmin MecinovićJasmin Mecinović
Jasmin Mecinović
DMDemetri T. Moustakas
Demetri T. Moustakas
STSamuel W. Thomas
Samuel W. Thomas
MHMichael Harder
Michael Harder
GWGeorge M. Whitesides
George M. Whitesides
The hydrophobic effect—a rationalization of the insolubility of nonpolar molecules in water—is centrally important to biomolecular recognition. Despite extensive research devoted to the hydrophobic effect, its molecular mechanisms remain controversial, and there are still no reliably predictive models for its role in protein–ligand binding. Here we describe a particularly well-defined system of protein and ligands—carbonic anhydrase and a series of structurally homologous heterocyclic aromatic sulfonamides—that we use to characterize hydrophobic interactions thermodynamically and structurally. In binding to this structurally rigid protein, a set of ligands (also defined to be structurally rigid) shows the expected gain in binding free energy as hydrophobic surface area is added. Isothermal titration calorimetry demonstrates that enthalpy determines these increases in binding affinity, and that changes in the heat capacity of binding are negative. X-ray crystallography and molecular dynamics simulations are compatible with the proposal that the differences in binding between the homologous ligands stem from changes in the number and organization of water molecules localized in the active site in the bound complexes, rather than (or perhaps in addition to) release of structured water from the apposed hydrophobic surfaces. These results support the hypothesis that structured water molecules—including both the molecules of water displaced by the ligands and those reorganized upon ligand binding—determine the thermodynamics of binding of these ligands at the active site of the protein. Hydrophobic effects in various contexts have different structural and thermodynamic origins, although all may be manifestations of the differences in characteristics of bulk water and water close to hydrophobic surfaces.

3 October 2013 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BBBenjamin Breiten
Benjamin Breiten
MLMatthew R. Lockett
Matthew R. Lockett
WSWoody Sherman
Woody Sherman
SFShuji Fujita
Shuji Fujita
MAMohammad Al-Sayah
Mohammad Al-Sayah
GWGeorge M. Whitesides
George M. Whitesides

25 April 2019 in ACS Chemical Biology
Verified
Journal Article
Open access
PGPaul R. Graves
Paul R. Graves
LALucas J. Aponte-Collazo
Lucas J. Aponte-Collazo
EFEmily M. J. Fennell
Emily M. J. Fennell
AGAdam C. Graves
Adam C. Graves
AHAndrew E. Hale
Andrew E. Hale
LGLee Graves
Lee Graves
ONC201 is a first-in-class imipridone molecule currently in clinical trials for the treatment of multiple cancers. Despite enormous clinical potential, the mechanism of action is controversial. To investigate the mechanism of ONC201 and identify compounds with improved potency, we tested a series of novel ONC201 analogs (TR compounds) for effects on cell viability and stress responses in breast and other cancer models. The TR compounds were found to be ~50-100 times more potent at inhibiting cell proliferation and inducing the integrated stress response (ISR) protein ATF4 than ONC201. Using immobilized TR compounds, we identified the human mitochondrial caseinolytic protease P (ClpP) as a specific binding protein by mass spectrometry. Affinity chromatography/drug competition assays showed that the TR compounds bound ClpP with ~10 fold higher affinity compared to ONC201. Importantly, we found that the peptidase activity of recombinant ClpP was strongly activated by ONC201 and the TR compounds in a dose- and time-dependent manner, with the TR compounds displaying a ~10-100 fold increase in potency over ONC201. Finally, siRNA knockdown of ClpP in SUM159 cells reduced the response to ONC201 and the TR compounds including induction of CHOP, loss of the mitochondrial proteins (TFAM, TUFM) and the cytostatic effects of these compounds. Thus, we report that ClpP directly binds ONC201 and the related TR compounds, and is an important biological target for this class of molecules. Moreover, these studies provide for the first time, a biochemical basis for the difference in efficacy between ONC201 and the TR compounds.

12 July 2011 in Environmental Science & Technology
Verified
Journal Article
Closed access
COCorey N. Olson
Corey N. Olson
MGMelissa M. Galloway
Melissa M. Galloway
GYGe Yu
Ge Yu
CHCurtis J. Hedman
Curtis J. Hedman
MLMatthew R. Lockett
Matthew R. Lockett
FKFrank N. Keutsch
Frank N. Keutsch

1 June 2015 in Biomaterials
Verified
Journal Article
Closed access
BMBobak Mosadegh
Bobak Mosadegh
MLMatthew R. Lockett
Matthew R. Lockett
KMKyaw Thu Minn
Kyaw Thu Minn
KSKaren A. Simon
Karen A. Simon
KGKarl Gilbert
Karl Gilbert
GWGeorge M. Whitesides
George M. Whitesides

12 February 2014 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
BMBobak Mosadegh
Bobak Mosadegh
BDBorna E. Dabiri
Borna E. Dabiri
MLMatthew R. Lockett
Matthew R. Lockett
RDRatmir Derda
Ratmir Derda
PCPatrick Campbell
Patrick Campbell
GWGeorge M. Whitesides
George M. Whitesides